INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 198 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $207,000 | -94.0% | 12,691 | -91.0% | 0.00% | -83.3% |
| Q4 2020 | $3,463,000 | +828.4% | 140,300 | +1458.9% | 0.01% | +500.0% |
| Q3 2020 | $373,000 | -56.7% | 9,000 | -50.0% | 0.00% | -66.7% |
| Q2 2020 | $862,000 | -82.6% | 18,000 | -55.0% | 0.00% | -83.3% |
| Q4 2019 | $4,957,000 | +151.0% | 40,000 | +33.3% | 0.02% | +157.1% |
| Q3 2019 | $1,975,000 | -24.3% | 30,000 | -77.4% | 0.01% | +16.7% |
| Q2 2019 | $2,610,000 | +736.5% | 133,000 | +4650.0% | 0.01% | +500.0% |
| Q1 2019 | $312,000 | +15500.0% | 2,800 | +17400.0% | 0.00% | – |
| Q4 2018 | $2,000 | -99.2% | 16 | -99.1% | 0.00% | -100.0% |
| Q3 2018 | $236,000 | -35.5% | 1,865 | -38.3% | 0.00% | 0.0% |
| Q2 2017 | $366,000 | -4.7% | 3,023 | +11.8% | 0.00% | 0.0% |
| Q2 2016 | $384,000 | -96.8% | 2,704 | -94.6% | 0.00% | -96.9% |
| Q3 2014 | $11,955,000 | +18.8% | 50,216 | +20.3% | 0.03% | +966.7% |
| Q2 2014 | $10,064,000 | +3084.8% | 41,739 | +4275.2% | 0.00% | – |
| Q1 2014 | $316,000 | -91.3% | 954 | -98.2% | 0.00% | -100.0% |
| Q4 2013 | $3,632,000 | +359.2% | 53,202 | +198.4% | 0.02% | +183.3% |
| Q2 2013 | $791,000 | +95.3% | 17,832 | +65.3% | 0.01% | +50.0% |
| Q1 2013 | $405,000 | -25.8% | 10,790 | -32.6% | 0.00% | -33.3% |
| Q4 2012 | $546,000 | – | 16,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |